Chronic Traumatic Encephalopathy and Its Future in Immunotherapy-Based Treatment

Authors

  • Nitya Kondaparthi Wakeland High School

DOI:

https://doi.org/10.47611/jsrhs.v12i4.5862

Keywords:

Chronic Traumatic Encephalopathy, CTE, Immunotherapy, Monoclonal-Antibody Therapy, Tau, Tauopathy, Pathogenic Tau, P-tau, Traumatic Brain Injuries, TBIs, mTBI, Concussions

Abstract

In the annals of medical history, few conditions have captured the world's attention and spurred a race for effective treatments quite like Chronic Traumatic Encephalopathy (CTE). Chronic traumatic encephalopathy (CTE) is a condition rarely studied and is quite a serious neurological disorder that is progressively debilitating. However, the reason why chronic traumatic encephalopathy is rarely studied is because only repeated concussions or traumatic brain injuries (TBIs) can cause CTE. As it so happens to be, many athletes who play close contact sports such as football, hockey, and rugby are at the most risk of developing this disorder. Although there is no definitive way to diagnose CTE during life (it can only be categorized as “probable” CTE), and can only be confirmed postmortem, scientists have identified the criteria and specific potential brain and blood biomarkers associated with CTE such as total tau (t-Tau), phosphorylated tau (p-Tau), neurofilament light chains(NfL), and amyloid-beta (Aβ), etc. These biomarkers could potentially help diagnose CTE while the individual who is suspected to have the disease is living. Furthermore, scientists have been researching immunotherapy, a new potential treatment for CTE. Throughout the following sections, this research article will navigate CTE and its clinical manifestations, pathology, and its implications on individuals and society. Subsequently, this article will discuss immunotherapy, uncovering the fundamental principles that underlie this approach, while highlighting its success in revolutionizing medical treatments for cancer, and the possibility of its future in treating chronic traumatic encephalopathy.

Downloads

Download data is not yet available.

References or Bibliography

Alipour, M., Tebianian, M., Tofigh, N., Taheri, R. S., Mousavi, S. A., Naseri, A., Ahmadi, A., Munawar, N., & Shahpasand, K. (2022). Active immunotherapy against pathogenic Cis pT231-tau suppresses neurodegeneration in traumatic brain injury mouse models. Neuropeptides, 96, 102285. https://doi.org/10.1016/j.npep.2022.102285

Alosco, M. L., Culhane, J., & Mez, J. (2021). Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic. Neurotherapeutics. https://doi.org/10.1007/s13311-021-01028-3

Alosco, M. L., Mariani, M. L., Adler, C. H., Balcer, L. J., Bernick, C., Au, R., Banks, S. J., Barr, W. B., Bouix, S., Cantu, R. C., Coleman, M. J., Dodick, D. W., Farrer, L. A., Geda, Y. E., Katz, D. I., Koerte, I. K., Kowall, N. W., Lin, A. P., Marcus, D. S., & Marek, K. L. (2021). Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project. Alzheimer’s Research & Therapy, 13(1). https://doi.org/10.1186/s13195-021-00872-x

Alzheimer's Association. (2021). Tau Topic Sheet. https://www.alz.org/media/documents/alzheimers-dementia-tau-ts.pdf

Alzheimer's Association. (2022). Chronic Traumatic Encephalopathy (CTE). Alzheimer’s Disease and Dementia. https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/chronic-traumatic-encephalopathy#:~:text=Chronic%20traumatic%20encephalopathy%20(CTE)%20is

Amir Mishan, M., Rezaei Kanavi, M., Shahpasand, K., & Ahmadieh, H. (2019). Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases. Journal of Ophthalmic and Vision Research, 14(4). https://doi.org/10.18502/jovr.v14i4.5459

Andtbacka, R. H. I., Kaufman, H. L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., Delman, K. A., Spitler, L. E., Puzanov, I., Agarwala, S. S., Milhem, M., Cranmer, L., Curti, B., Lewis, K., Ross, M., Guthrie, T., Linette, G. P., Daniels, G. A., Harrington, K., & Middleton, M. R. (2015). Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. Journal of Clinical Oncology, 33(25), 2780–2788. https://doi.org/10.1200/jco.2014.58.3377

Baas, P. W., Rao, A. N., Matamoros, A. J., & Leo, L. (2016). Stability properties of neuronal microtubules. Cytoskeleton, 73(9), 442–460. https://doi.org/10.1002/cm.21286

Boston University. (2021, March 17). Criteria Set for Diagnosing CTE Symptoms in Living People | SPH. Www.bu.edu. https://www.bu.edu/sph/news/articles/2021/new-criteria-for-diagnosing-cte-symptoms-during-life/

Boston University. (2022, March 4). Additional Years of Ice Hockey Play May Be Linked to Greater Chance of CTE Chobanian & Avedisian School of Medicine. Www.bumc.bu.edu. https://www.bumc.bu.edu/camed/2022/03/04/additional-years-of-ice-hockey-play-may-be-linked-to-greater-chance-of-cte/

Bower, A. (2023, April 4). 100 former rugby league players start legal fight with RFL over brain injuries. The Guardian. https://www.theguardian.com/sport/2023/apr/04/rugby-league-brain-injuries-former-players-legal-fight-rfl

Breen, P. W., & Krishnan, V. (2020). Recent Preclinical Insights Into the Treatment of Chronic Traumatic Encephalopathy. Frontiers in Molecular Neuroscience. https://www.frontiersin.org/articles/10.3389/fnins.2020.00616/full#B17

BU Research CTE Center. (n.d.-a). Brain Donation | CTE Center. Www.bu.edu. https://www.bu.edu/cte/brain-donation-registry/

BU Research CTE Center. (n.d.-b). Participate in Research | CTE Center. Www.bu.edu. Retrieved August 31, 2023, from https://www.bu.edu/cte/our-research/participate-in-research/

Butterfield, D. A., Abdul, H. M., Opii, W., Newman, S. F., Joshi, G., Ansari, M. A., & Sultana, R. (2006). REVIEW: Pin1 in Alzheimer’s disease. Journal of Neurochemistry, 98(6), 1697–1706. https://doi.org/10.1111/j.1471-4159.2006.03995.x

Cancer Research Institute. (n.d.). Immunotherapy Side Effects. Cancer Research Institute. https://www.cancerresearch.org/immunotherapy-side-effects

Cancer Research UK. (2020, June 10). How chemotherapy works | Cancer in general | Cancer Research UK. Www.cancerresearchuk.org. https://www.cancerresearchuk.org/about-cancer/treatment/chemotherapy/how-chemotherapy-works#:~:text=Chemotherapy%20damages%20the%20genes%20inside

CANCER.NET. (2012, November 9). What is Chemotherapy? Cancer.net. https://www.cancer.net/navigating-cancer-care/how-cancer-treated/chemotherapy/what-chemotherapy

Cherry, J. D., Stein, T. D., Tripodis, Y., Alvarez, V. E., Huber, B. R., Au, R., Kiernan, P. T., Daneshvar, D. H., Mez, J., Solomon, T. M., Alosco, M. L., & McKee, A. C. (2017). CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer’s disease. PLOS ONE, 12(9), e0185541. https://doi.org/10.1371/journal.pone.0185541

Cleveland Clinic. (2018). Chronic traumatic encephalopathy (CTE) | Cleveland Clinic. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17686-chronic-traumatic-encephalopathy-cte

Concussion Legacy Foundation. (n.d.-a). Brain Banks | Concussion Legacy Foundation. Concussionfoundation.org. https://concussionfoundation.org/programs/brain-banks

Concussion Legacy Foundation. (n.d.-b). Living with CTE | Concussion Legacy Foundation. Concussionfoundation.org. Retrieved August 29, 2023, from https://concussionfoundation.org/CTE-resources/living-with-CTE#:~:text=Talk%20to%20your%20doctor.

Concussion Legacy Foundation. (2018, November 6). What Is CTE? Concussion Legacy Foundation; Concussion Legacy Foundation. https://concussionfoundation.org/CTE-resources/what-is-CTE

Concussions, C. (2018, December 6). What Sport Has The Most Concussions? | Concussion Rate. Complete Concussions. https://completeconcussions.com/concussion-research/concussion-rates-what-sport-most-concussions/

Congdon, E. E., Chukwu, J. E., Shamir, D. B., Deng, J., Ujla, D., Sait, H. B. R., Neubert, T. A., Kong, X.-P., & Sigurdsson, E. M. (2017). Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy. The Lancelet. https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(19)30173-2/fulltext

Conti, A., Kamimura, H. A. S., Novell, A., Duggento, A., & Toschi, N. (2020). Magnetic Resonance Methods for Focused Ultrasound-Induced Blood-Brain Barrier Opening. Frontiers in Physics. https://www.frontiersin.org/articles/10.3389/fphy.2020.547674/full

D’Ascanio, S., Alosco, M. L., & Stern, R. A. (2018, January 1). Chapter 27 - Chronic traumatic encephalopathy: clinical presentation and in vivo diagnosis (B. Hainline & R. A. Stern, Eds.). ScienceDirect; Elsevier. https://www.sciencedirect.com/science/article/abs/pii/B9780444639547000276?via%3Dihub

Denise Mann Healthday. (2023, February 9). In Autopsy Study, Over 90% of Former NFL Players Showed Signs of Brain Disease CTE. https://www.usnews.com/news/health-news/articles/2023-02-09/in-autopsy-study-over-90-of-former-nfl-players-showed-signs-of-brain-disease-cte#:~:text=The%20new%20research%20builds%20on,in%20the%20UNITE%20brain%20bank.

DIAGNOSE CTE. (n.d.). What is Chronic Traumatic Encephalopathy (CTE)? DIAGNOSE CTE. Retrieved August 15, 2023, from https://diagnosecte.com/what-is-cte

Dickstein, D. L., De Gasperi, R., Gama Sosa, M. A., Perez-Garcia, G., Short, J. A., Sosa, H., Perez, G. M., Tschiffely, A. E., Dams-O’Connor, K., Pullman, M. Y., Knesaurek, K., Knutsen, A., Pham, D. L., Soleimani, L., Jordan, B. D., Gordon, W. A., Delman, B. N., Shumyatsky, G., Shahim, P.-P., & DeKosky, S. T. (2021). Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure. Molecular Psychiatry, 26(10), 5940–5954. https://doi.org/10.1038/s41380-020-0674-z

Emfietzoglou, M. (n.d.). Corpus Callosum: What Is It, Location, Function, and More | Osmosis. Www.osmosis.org. https://www.osmosis.org/answers/corpus-callosum#:~:text=The%20corpus%20callosum%20is%20a

Gardner, R. C., & Yaffe, K. (2015). Epidemiology of mild traumatic brain injury and neurodegenerative disease. Molecular and Cellular Neuroscience, 66, 75–80. https://doi.org/10.1016/j.mcn.2015.03.001

Ge, X., Guo, M., Li, M., Zhang, S., Qiang, J., Zhu, L., Cheng, L., Li, W., Wang, Y., Yu, J., Yin, Z., Chen, F., Tong, W., & Lei, P. (2022). Potential blood biomarkers for chronic traumatic encephalopathy: The multi-omics landscape of an observational cohort. Frontiers in Aging Neuroscience, 14. https://doi.org/10.3389/fnagi.2022.1052765

Georges, A., & M Das, J. (2022). Traumatic Brain Injury. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459300/#:~:text=Statistically%2C%20the%20Center%20for%20Disease

Gerges, J. A., Chalhoub, I., Atallah, C., & Khoury, R. (2023). Biomarkers of chronic traumatic encephalopathy: A state-of-the art review. Biomarkers in Neuropsychiatry, 8, 100066. https://doi.org/10.1016/j.bionps.2023.100066

Goldstein, A., Covington, B. P., Mahabadi, N., & Mesfin, F. B. (2020). Neuroanatomy, Corpus Callosum. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK448209/#:~:text=The%20corpus%20callosum%20is%20the

Gonçalves, R. A., Wijesekara, N., Fraser, P. E., & De Felice, F. G. (2020). Behavioral Abnormalities in Knockout and Humanized Tau Mice. Frontiers in Endocrinology, 11. https://doi.org/10.3389/fendo.2020.00124

Gong, C.-X. ., & Iqbal, K. (2008). Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease. Current Medicinal Chemistry, 15(23), 2321–2328. https://www.eurekaselect.com/article/12670

Hill, E., Wall, M. J., Moffat, K. G., & Karikari, T. K. (2020). Understanding the Pathophysiological Actions of Tau Oligomers: A Critical Review of Current Electrophysiological Approaches.Frontiers in Molecular Neuroscience , 13. https://doi.org/10.3389/fnmol.2020.00155

Hynynen, K., McDannold, N., Vykhodtseva, N., & Jolesz, F. A. (2001). Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits. Radiology, 220(3), 640–646. https://doi.org/10.1148/radiol.2202001804

Kondo, A., Shahpasand, K., Mannix, R., Qiu, J., Moncaster, J., Chen, C.-H., Yao, Y., Lin, Y.-M., Driver, J. A., Sun, Y., Wei, S., Luo, M.-L., Albayram, O., Huang, P., Rotenberg, A., Ryo, A., Goldstein, L. E., Pascual-Leone, A., McKee, A. C., & Meehan, W. (2015). Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature, 523(7561), 431–436. https://doi.org/10.1038/nature14658

M Das, J., & Dossani, R. H. (2022). Cavum Septum Pellucidum. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK537048/#:~:text=The%20cavum%20septum%20pellucidum%20(CSP

Mayo Clinic. (2016). Chronic traumatic encephalopathy - Symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/chronic-traumatic-encephalopathy/symptoms-causes/syc-20370921

McKee, A. C., Stein, T. D., Kiernan, P. T., & Alvarez, V. E. (2015). The Neuropathology of Chronic Traumatic Encephalopathy. Brain Pathology, 25(3), 350–364. https://doi.org/10.1111/bpa.12248

Mez, J. (2017). Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football. JAMA, 318(4), 360–370. https://doi.org/10.1001/jama.2017.8334

Moran, B. (2017, July 26). BU Researchers Find CTE in 99% of Former NFL Players Studied. Boston University. https://www.bu.edu/articles/2017/cte-former-nfl-players/

Murray, H. C., Osterman, C., Bell, P., Vinnell, L., & Curtis, M. A. (2022). Neuropathology in chronic traumatic encephalopathy: a systematic review of comparative post-mortem histology literature. Acta Neuropathologica Communications, 10(1). https://doi.org/10.1186/s40478-022-01413-9

National Institute of Neurological Disorders and Stroke. (n.d.). The DIAGNOSE-CTE Research Project | National Institute of Neurological Disorders and Stroke. Www.ninds.nih.gov. https://www.ninds.nih.gov/health-information/clinical-trials/diagnose-cte-research-project

Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013). The Importance of Tau Phosphorylation for Neurodegenerative Diseases. Frontiers in Neurology, 4(83). https://doi.org/10.3389/fneur.2013.00083

Peterson, D. C., Reddy, V., & Mayes, D. A. (2021, August 11). Neuroanatomy, Mammillary Bodies. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK537192/#:~:text=The%20mammillary%20bodies%20are%20brainstem

Prasuhn, J., Prasuhn, M., Fellbrich, A., Strautz, R., Lemmer, F., Dreischmeier, S., Kasten, M., Münte, T. F., Hanssen, H., Heldmann, M., & Brüggemann, N. (2021). Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease. Neurology, 97(10), e1007–e1016. https://doi.org/10.1212/WNL.0000000000012444

Rimer, S. (2017). Possible Biomarker for Diagnosing CTE during Life | The Brink. Boston University. https://www.bu.edu/articles/2017/diagnosing-cte-during-life/

Sigurdsson, E. M. (2018). Tau Immunotherapies for Alzheimer’s Disease and Related Tauopathies: Progress and Potential Pitfalls1. Journal of Alzheimer’s Disease, 64(s1), S555–S565. https://doi.org/10.3233/jad-179937

Tao, A., Pan, Y., Myslinski, Z., Iadecola, C., Dyke, J., Chiang, G., & Ishii, M. (2021). Atrophy of mammillary bodies in early stages of Alzheimer’s disease. Alzheimer’s & Dementia, 17(S4). https://doi.org/10.1002/alz.050729

Tarter, R. E., Kirisci, L., Mezzich, A., Cornelius, J. R., Pajer, K., Vanyukov, M., Gardner, W., Blackson, T., & Clark, D. (2003). Neurobehavioral Disinhibition in Childhood Predicts Early Age at Onset of Substance Use Disorder. American Journal of Psychiatry, 160(6), 1078–1085. https://doi.org/10.1176/appi.ajp.160.6.1078

Turk, K. W., Geada, A., Alvarez, V. E., Xia, W., Cherry, J. D., Nicks, R., Meng, G., Daley, S., Tripodis, Y., Huber, B. R., Budson, A. E., Dwyer, B., Kowall, N. W., Cantu, R. C., Goldstein, L. E., Katz, D. I., Stern, R. A., Alosco, M. L., Mez, J., & McKee, A. C. (2022). A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer's disease. Alzheimer’s Research & Therapy, 14(1). https://doi.org/10.1186/s13195-022-00976-y

UT Southwestern Medical Center. (2019, August 21). Largest Texas high schools to report all concussions to statewide registry. Www.utsouthwestern.edu. https://www.utsouthwestern.edu/newsroom/articles/year-2019/texas-high-schools-report-concussions.html

Vanltallie, T. B. (2019). Traumatic brain injury (TBI) in collision sports: Possible mechanisms of transformation into chronic traumatic encephalopathy (CTE). Metabolism, 100, 153943. https://doi.org/10.1016/j.metabol.2019.07.007

Zhang, Y., & Zhang, Z. (2020). The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cellular & Molecular Immunology, 17(8), 1–15. https://doi.org/10.1038/s41423-020-0488-6

Zhou, Y., Thompson, P. M., & Toga, A. W. (1999). Extracting and representing the cortical sulci. IEEE Computer Graphics and Applications, 19(3), 49–55. https://doi.org/10.1109/38.761550

Published

11-30-2023

How to Cite

Kondaparthi, N. (2023). Chronic Traumatic Encephalopathy and Its Future in Immunotherapy-Based Treatment. Journal of Student Research, 12(4). https://doi.org/10.47611/jsrhs.v12i4.5862

Issue

Section

HS Review Articles